Cargando…
Polycystic Ovary Syndrome, Combined Oral Contraceptives, and the Risk of Dysglycemia: A Population-Based Cohort Study With a Nested Pharmacoepidemiological Case-Control Study
OBJECTIVE: Irregular menstrual cycles are associated with increased cardiovascular mortality. Polycystic ovary syndrome (PCOS) is characterized by androgen excess and irregular menses; androgens are drivers of increased metabolic risk in women with PCOS. Combined oral contraceptive pills (COCPs) are...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669537/ https://www.ncbi.nlm.nih.gov/pubmed/34649997 http://dx.doi.org/10.2337/dc21-0437 |
_version_ | 1784614799509815296 |
---|---|
author | Kumarendran, Balachandran O'Reilly, Michael W. Subramanian, Anuradhaa Šumilo, Dana Toulis, Konstantinos Gokhale, Krishna M. Wijeratne, Chandrika N. Coomarasamy, Arri Tahrani, Abd A. Azoulay, Laurent Arlt, Wiebke Nirantharakumar, Krishnarajah |
author_facet | Kumarendran, Balachandran O'Reilly, Michael W. Subramanian, Anuradhaa Šumilo, Dana Toulis, Konstantinos Gokhale, Krishna M. Wijeratne, Chandrika N. Coomarasamy, Arri Tahrani, Abd A. Azoulay, Laurent Arlt, Wiebke Nirantharakumar, Krishnarajah |
author_sort | Kumarendran, Balachandran |
collection | PubMed |
description | OBJECTIVE: Irregular menstrual cycles are associated with increased cardiovascular mortality. Polycystic ovary syndrome (PCOS) is characterized by androgen excess and irregular menses; androgens are drivers of increased metabolic risk in women with PCOS. Combined oral contraceptive pills (COCPs) are used in PCOS both for cycle regulation and to reduce the biologically active androgen fraction. We examined COCP use and risk of dysglycemia (prediabetes and type 2 diabetes) in women with PCOS. RESEARCH DESIGN AND METHODS: Using a large U.K. primary care database (The Health Improvement Network [THIN]; 3.7 million patients from 787 practices), we carried out a retrospective population-based cohort study to determine dysglycemia risk (64,051 women with PCOS and 123,545 matched control subjects), as well as a nested pharmacoepidemiological case-control study to investigate COCP use in relation to dysglycemia risk (2,407 women with PCOS with [case subjects] and without [control subjects] a diagnosis of dysglycemia during follow-up). Cox models were used to estimate the unadjusted and adjusted hazard ratio, and conditional logistic regression was used to obtain adjusted odds ratios (aORs). RESULTS: The adjusted hazard ratio for dysglycemia in women with PCOS was 1.87 (95% CI 1.78–1.97, P < 0.001; adjustment for age, social deprivation, BMI, ethnicity, and smoking), with increased rates of dysglycemia in all BMI subgroups. Women with PCOS and COCP use had a reduced dysglycemia risk (aOR 0.72, 95% CI 0.59–0.87). CONCLUSIONS: In this study, limited by its retrospective nature and the use of routinely collected electronic general practice record data, which does not allow for exclusion of the impact of prescription-by-indication bias, women with PCOS exposed to COCPs had a reduced risk of dysglycemia across all BMI subgroups. Future prospective studies should be considered for further understanding of these observations and potential causality. |
format | Online Article Text |
id | pubmed-8669537 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-86695372021-12-28 Polycystic Ovary Syndrome, Combined Oral Contraceptives, and the Risk of Dysglycemia: A Population-Based Cohort Study With a Nested Pharmacoepidemiological Case-Control Study Kumarendran, Balachandran O'Reilly, Michael W. Subramanian, Anuradhaa Šumilo, Dana Toulis, Konstantinos Gokhale, Krishna M. Wijeratne, Chandrika N. Coomarasamy, Arri Tahrani, Abd A. Azoulay, Laurent Arlt, Wiebke Nirantharakumar, Krishnarajah Diabetes Care Cardiovascular and Metabolic Risk OBJECTIVE: Irregular menstrual cycles are associated with increased cardiovascular mortality. Polycystic ovary syndrome (PCOS) is characterized by androgen excess and irregular menses; androgens are drivers of increased metabolic risk in women with PCOS. Combined oral contraceptive pills (COCPs) are used in PCOS both for cycle regulation and to reduce the biologically active androgen fraction. We examined COCP use and risk of dysglycemia (prediabetes and type 2 diabetes) in women with PCOS. RESEARCH DESIGN AND METHODS: Using a large U.K. primary care database (The Health Improvement Network [THIN]; 3.7 million patients from 787 practices), we carried out a retrospective population-based cohort study to determine dysglycemia risk (64,051 women with PCOS and 123,545 matched control subjects), as well as a nested pharmacoepidemiological case-control study to investigate COCP use in relation to dysglycemia risk (2,407 women with PCOS with [case subjects] and without [control subjects] a diagnosis of dysglycemia during follow-up). Cox models were used to estimate the unadjusted and adjusted hazard ratio, and conditional logistic regression was used to obtain adjusted odds ratios (aORs). RESULTS: The adjusted hazard ratio for dysglycemia in women with PCOS was 1.87 (95% CI 1.78–1.97, P < 0.001; adjustment for age, social deprivation, BMI, ethnicity, and smoking), with increased rates of dysglycemia in all BMI subgroups. Women with PCOS and COCP use had a reduced dysglycemia risk (aOR 0.72, 95% CI 0.59–0.87). CONCLUSIONS: In this study, limited by its retrospective nature and the use of routinely collected electronic general practice record data, which does not allow for exclusion of the impact of prescription-by-indication bias, women with PCOS exposed to COCPs had a reduced risk of dysglycemia across all BMI subgroups. Future prospective studies should be considered for further understanding of these observations and potential causality. American Diabetes Association 2021-12 2021-10-15 /pmc/articles/PMC8669537/ /pubmed/34649997 http://dx.doi.org/10.2337/dc21-0437 Text en © 2021 by the American Diabetes Association https://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license. |
spellingShingle | Cardiovascular and Metabolic Risk Kumarendran, Balachandran O'Reilly, Michael W. Subramanian, Anuradhaa Šumilo, Dana Toulis, Konstantinos Gokhale, Krishna M. Wijeratne, Chandrika N. Coomarasamy, Arri Tahrani, Abd A. Azoulay, Laurent Arlt, Wiebke Nirantharakumar, Krishnarajah Polycystic Ovary Syndrome, Combined Oral Contraceptives, and the Risk of Dysglycemia: A Population-Based Cohort Study With a Nested Pharmacoepidemiological Case-Control Study |
title | Polycystic Ovary Syndrome, Combined Oral Contraceptives, and the Risk of Dysglycemia: A Population-Based Cohort Study With a Nested Pharmacoepidemiological Case-Control Study |
title_full | Polycystic Ovary Syndrome, Combined Oral Contraceptives, and the Risk of Dysglycemia: A Population-Based Cohort Study With a Nested Pharmacoepidemiological Case-Control Study |
title_fullStr | Polycystic Ovary Syndrome, Combined Oral Contraceptives, and the Risk of Dysglycemia: A Population-Based Cohort Study With a Nested Pharmacoepidemiological Case-Control Study |
title_full_unstemmed | Polycystic Ovary Syndrome, Combined Oral Contraceptives, and the Risk of Dysglycemia: A Population-Based Cohort Study With a Nested Pharmacoepidemiological Case-Control Study |
title_short | Polycystic Ovary Syndrome, Combined Oral Contraceptives, and the Risk of Dysglycemia: A Population-Based Cohort Study With a Nested Pharmacoepidemiological Case-Control Study |
title_sort | polycystic ovary syndrome, combined oral contraceptives, and the risk of dysglycemia: a population-based cohort study with a nested pharmacoepidemiological case-control study |
topic | Cardiovascular and Metabolic Risk |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669537/ https://www.ncbi.nlm.nih.gov/pubmed/34649997 http://dx.doi.org/10.2337/dc21-0437 |
work_keys_str_mv | AT kumarendranbalachandran polycysticovarysyndromecombinedoralcontraceptivesandtheriskofdysglycemiaapopulationbasedcohortstudywithanestedpharmacoepidemiologicalcasecontrolstudy AT oreillymichaelw polycysticovarysyndromecombinedoralcontraceptivesandtheriskofdysglycemiaapopulationbasedcohortstudywithanestedpharmacoepidemiologicalcasecontrolstudy AT subramaniananuradhaa polycysticovarysyndromecombinedoralcontraceptivesandtheriskofdysglycemiaapopulationbasedcohortstudywithanestedpharmacoepidemiologicalcasecontrolstudy AT sumilodana polycysticovarysyndromecombinedoralcontraceptivesandtheriskofdysglycemiaapopulationbasedcohortstudywithanestedpharmacoepidemiologicalcasecontrolstudy AT touliskonstantinos polycysticovarysyndromecombinedoralcontraceptivesandtheriskofdysglycemiaapopulationbasedcohortstudywithanestedpharmacoepidemiologicalcasecontrolstudy AT gokhalekrishnam polycysticovarysyndromecombinedoralcontraceptivesandtheriskofdysglycemiaapopulationbasedcohortstudywithanestedpharmacoepidemiologicalcasecontrolstudy AT wijeratnechandrikan polycysticovarysyndromecombinedoralcontraceptivesandtheriskofdysglycemiaapopulationbasedcohortstudywithanestedpharmacoepidemiologicalcasecontrolstudy AT coomarasamyarri polycysticovarysyndromecombinedoralcontraceptivesandtheriskofdysglycemiaapopulationbasedcohortstudywithanestedpharmacoepidemiologicalcasecontrolstudy AT tahraniabda polycysticovarysyndromecombinedoralcontraceptivesandtheriskofdysglycemiaapopulationbasedcohortstudywithanestedpharmacoepidemiologicalcasecontrolstudy AT azoulaylaurent polycysticovarysyndromecombinedoralcontraceptivesandtheriskofdysglycemiaapopulationbasedcohortstudywithanestedpharmacoepidemiologicalcasecontrolstudy AT arltwiebke polycysticovarysyndromecombinedoralcontraceptivesandtheriskofdysglycemiaapopulationbasedcohortstudywithanestedpharmacoepidemiologicalcasecontrolstudy AT nirantharakumarkrishnarajah polycysticovarysyndromecombinedoralcontraceptivesandtheriskofdysglycemiaapopulationbasedcohortstudywithanestedpharmacoepidemiologicalcasecontrolstudy |